ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 139 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,548 | -5.7% | 4,424 | +2.5% | 0.00% | – |
| Q2 2023 | $6,947 | -47.8% | 4,315 | -6.0% | 0.00% | – |
| Q1 2023 | $13,307 | -15.7% | 4,589 | -1.4% | 0.00% | – |
| Q4 2022 | $15,792 | +426.4% | 4,655 | +447.0% | 0.00% | – |
| Q3 2022 | $3,000 | -57.1% | 851 | -2.0% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 868 | +15.0% | 0.00% | – |
| Q1 2022 | $7,000 | -50.0% | 755 | -14.0% | 0.00% | – |
| Q4 2021 | $14,000 | +27.3% | 878 | +36.8% | 0.00% | – |
| Q3 2021 | $11,000 | -47.6% | 642 | -50.3% | 0.00% | – |
| Q2 2021 | $21,000 | +10.5% | 1,291 | -5.4% | 0.00% | – |
| Q1 2021 | $19,000 | -96.8% | 1,365 | -95.6% | 0.00% | -100.0% |
| Q4 2020 | $602,000 | +78.1% | 30,703 | +17.7% | 0.00% | +100.0% |
| Q3 2020 | $338,000 | +8350.0% | 26,090 | +7573.5% | 0.00% | – |
| Q2 2020 | $4,000 | -50.0% | 340 | -63.0% | 0.00% | – |
| Q1 2020 | $8,000 | – | 920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
| M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
| Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
| MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
| Baupost Group | 8,123,616 | $26,645 | 0.44% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
| WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
| STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
| Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |